Pierre Kyme Ph.D Overview

  • Primary Position
  • Chief Business...

Pierre Kyme Ph.D General Information

Biography

Dr. Pierre Kyme serves as Chief Business Officer at Armata Pharmaceuticals. He was appointed to this position in June 2024. He also currently serves as a member of the boards of directors of Armata's Australian subsidiaries. He is devoted to Armata's business and corporate development activities, a role that started at C3J Therapeutics in 2015. Previously, he served as a lead Scientist and Director of Product Development at C3J Therapeutics from 2012, leading a team that set strategy and delivered key data essential for advancing a lead antimicrobial molecule through Phase 2 human clinical trials. He also contributed to the company's pipeline programs, providing a medical and commercial rationale to justify pipeline expansion. Before joining Armata, he spent 5 years maturing his drug development career at Cedars-Sinai Medical Center leading project teams from concept through preclinical research in infectious disease and immunology. In this capacity, he worked closely with the Technology Transfer Office and was the recipient of the Malaniak Award for Excellence in Research. Before this, in partnership with Qiagen Pty. Ltd., he worked at Sydney's Millennium Institute, as part of a priority national grant for urgent research into avian influenza. He has also served as a Scientific Advisor for the Australia Desk and Life Sciences & Healthcare Practice at Cappello Global, a boutique investment bank, and as a consultant analyst to a global specialist life sciences investment firm, evaluating multiple therapeutic areas. His work contributed to capital raising for a private U.S. oncology biotech, which in 2012 initiated the world's largest Phase 3 human clinical trial for a melanoma vaccine. He earned his Ph.D. in Medicine from the University of Sydney, Australia, the bulk of which was accomplished as an invited scholar at the University of Tübingen, Germany. He completed his postdoctoral training at the Michael Smith Laboratories in Vancouver, Canada, under a grant from the Gates Foundation Grand Challenges in Global Health initiative, developing Innate Defense Regulators in partnership with Inimex Pharmaceuticals (acquired by Soligenix).

Contact Information

Primary Position
Chief Business Officer, Armata Pharmaceuticals
Education
University of Sydney, Ph.D. (Doctor of Philosophy)
University of Sydney, BS (Bachelor of Science) Honors
Gender
Male
Email
pk
Phone
+1 (310)
Address
  • 5005 McConnell Avenue
  • Los Angeles, CA 90066
  • United States
+1 (310)

Pierre Kyme Ph.D Positions (1)

Firm name Firm type Title Location Industry Since
Armata Pharmaceuticals Company Chief Business Officer Los Angeles, CA Drug Discovery

Pierre Kyme Ph.D FAQs

  • Who is Pierre Kyme Ph.D?

    Dr. Pierre Kyme serves as Chief Business Officer at Armata Pharmaceuticals.

  • How much does Pierre Kyme Ph.D typically invest?

    Pierre Kyme Ph.D's median deal size is .

  • What is Pierre Kyme Ph.D’s main position?

    Pierre Kyme Ph.D’s primary position is Chief Business Officer.

  • What are the contact details for Pierre Kyme Ph.D?

    Pierre Kyme Ph.D’s email address is pk and his phone number is +1 (310) .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »